Restricted accessLetterFirst published online 2020-02
The Inhibition of the Histone Methyltransferase EZH2 by DZNEP or SiRNA Demonstrates Its Involvement in MGMT,TRA2A,RPS6KA2,and U2AF1 Gene Regulation in Prostate Cancer
BrayF, FerlayJ, SoerjomataramI, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68, 394–424.
2.
ChngKR, ChangCW, TanSK, et al. (2012). A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. Embo J, 31, 2810–2823.
3.
DauresM, IdrissouM, JudesG, et al. (2018). A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2. Oncotarget, 9, 23413–23425.
4.
MassieCE, LynchA, Ramos-MontoyaA, et al. (2011). The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. Embo J, 30, 2719–2733.
5.
NgolloM, LebertA, DagdemirA, et al. (2014). The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: Relationship with clinicopathological parameters. BMC Cancer, 14, 994.
6.
NgolloM, LebertA, DauresM, et al. (2017). Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression. BMC Cancer, 17, 261.
7.
ZhaoJC, YuJ, RunkleC, et al. (2012). Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res, 22, 322–331.
